| 1 |
35323988 | TP53 loss‑of‑function mutations reduce sensitivity of acute leukaemia to the curaxin CBL0137. | 2022 May |
7 |
| 2 |
33852836 | Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. | 2021 Apr 13 |
1 |
| 3 |
32202904 | CBL0137 administration suppresses human hepatocellular carcinoma cells proliferation and induces apoptosis associated with multiple cell death related proteins. | 2020 May |
2 |
| 4 |
27370399 | Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. | 2017 Feb 1 |
2 |